Pharmacogenetic and pharmacogenomic considerations of asthma treatment
| Autor: | Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera, Barbara Rinaldi |
|---|---|
| Přispěvatelé: | Matera, Maria Gabriella, Rinaldi, Barbara, Calzetta, L, Cazzola, M. |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Asthma treatment Inhaled corticosteroids Disease Pharmacology Toxicology Polymorphism Single Nucleotide Epigenesis Genetic 03 medical and health sciences medicine Humans Anti-Asthmatic Agents Intensive care medicine Asthma business.industry Patient Selection General Medicine medicine.disease 030104 developmental biology Pharmacogenetics Pharmacogenomics Asthma inhaled corticosteroids leukotriene modifiers pharmacogenetics pharmacogenomics β2-adrenoceptor agonists business |
| Zdroj: | Expert opinion on drug metabolismtoxicology. 13(11) |
| ISSN: | 1744-7607 |
| Popis: | Pharmacogenetic and pharmacogenomic approaches are already utilized in some areas, such as oncology and cardiovascular disease, for selecting appropriate patients and/or establishing treatment and dosing guidelines. This is not true in asthma although many patients have different responses to drug treatment due to genetic factors. Areas covered: Several genetic factors that affect the pharmacotherapeutic responses to asthma medications, such as β |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|